Dr. R Shrikanth Specialist in Medical Oncology

Area of Expertise

● Dr. Shrikanth Ravichandran has got an overall experience of more than 2 years in the field of Oncology

● He has been a part of the clinical trial wing at GCRI and has research experience

● He has a vast experience in the management of all types of solid and hematologic malignancies with chemotherapy, targeted therapy and immunotherapy

● He also has experience in treatment of pediatric malignancies

● He has been part of an experienced BMT team led by Dr. Sandip Shah, a pioneer of BMT in India, involved in numerous Autologous and Allogenic stem cell transplants

Research & Publications

● Isolated CNS relapse in a case of pancreatic plasmablastic lymphoma. Gujarat Cancer Society Research Journal; vol 25; number 2; October 2023. Pg 32-35

● Co PI in clinical trial in GCRI: A multicenter, open-label, randomized, phase III clinical trial to evaluate efficacy and safety of PF-114 versus imatinib at 600 or 800 mg daily in adult patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase (CP) resistant to imatinib at daily doses of 400 or 600 mg.

Awards & Accolades

● Won 1st place in Hemfest 2019, hematology state level quiz in IGGMC Nagpur, Maharashtra

● Runner up in COPE National Gold medal exam conducted in Adyar cancer institute (April 2023)

● Dr. Shrikanth has certification in medical oncology from FRCP/ACP UK

● Dr. Shrikanth has certification in medical oncology from European Society of Medical Oncology (ESMO)

Other Doctors